Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new Revision: v3.6.4 is now listed in the study record history, replacing the previous Revision: v3.6.3. This reflects a minor update to the page interface rather than changes to the study data.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.6.3 has been added to the study's history, superseding the previous v3.6.2 entry.SummaryDifference0.1%

- Check37 days agoChange DetectedThe history section now shows a newer software revision (v3.6.2) replacing the older v3.6.0, indicating a background deployment that updates how history is displayed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe record now shows the study is Completed and no longer looking for participants, with the Recruitment Status and Study Status sections updated accordingly to reflect the end of recruitment.SummaryDifference2%

- Check58 days agoChange DetectedA new revision entry Revision: v3.5.5 has been added to the history, replacing the prior Revision: v3.5.4. This indicates an update to the page's version history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history now shows a new revision, v3.5.4, as the latest entry, replacing the prior v3.5.3. This reflects a minor update to the page's version history rather than content changes.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.